Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2010
09/01/2010CN101816723A Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof
09/01/2010CN101816712A Chinese medicinal composition for treating trigeminal neuralgia
09/01/2010CN101816691A Gensenosides osmotic pump capsule and preparation method thereof
09/01/2010CN101816690A Gensenoside double-layer osmotic pump tablet and preparation method thereof
09/01/2010CN101816673A Medicinal preparation containing levodopa and cytidine diphosphate and application thereof in treating parkinson diseases
09/01/2010CN101816657A Process for preparing vinegar powder soft capsules
09/01/2010CN101816656A Formula of vinegar powder soft capsules
09/01/2010CN101816655A Medicinal preparation containing repaglinide and ligustrazine and application thereof in diabetic complications
09/01/2010CN101816654A Medicinal combination of nalmefene hydrochloride and polyvinyl pyrrolidone and preparation method thereof
09/01/2010CN101816313A Chinese medicinal camphor ball
09/01/2010CN101433545B Use of bioflavanoid or polyphenolic substance for treating parkinson's disease
09/01/2010CN101313908B Composition for treating autonomic nerve disorder, preparation and uses thereof
09/01/2010CN101292972B Use of 3,4-dihydroxy coffee acyl group tartaric acid in preparing medicaments for treating dementia diseases
09/01/2010CN101288761B Chinese tmedicine preparation for treating depression and its preparation method
09/01/2010CN101269179B Traditional Chinese medicine preparation for treating senile dementia and preparation method thereof
09/01/2010CN101264058B Huperzine A and its derivative or salts sustained-release nanometer granule and preparing method thereof
09/01/2010CN101255422B siRNA sequence suppressing expression of bax gene
09/01/2010CN101209266B Compound sobering-up agent
09/01/2010CN101204378B Memantine hydrochloride oral medicine compound and its preparation method
09/01/2010CN101190327B 'Kanlijiaobuye' a kind of traditional Chinese medicinal oral liquid
09/01/2010CN101085062B Medicine for curing parkinson's disease and its preparing method
09/01/2010CN101057678B Composition containing natural plant extraction or monomer
08/2010
08/31/2010US7786311 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
08/31/2010US7786147 used for the treatment of Parkinson's disease, Huntington disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, ataxia, Pick's disease, Pick's disease, vision defects, Cruetzfelt-Jacob syndrome or Alzheimer's disease
08/31/2010US7786140 Piperidine derivative having NMDA receptor antagonistic activity
08/31/2010US7786135 Substituted pyrroline kinase inhibitors
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786105 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease
08/31/2010US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
08/31/2010US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease
08/31/2010US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring
08/31/2010US7785833 Methods and means for producing proteins with predetermined post-translational modifications
08/31/2010US7785819 Diagnosis of autoimmune disease; generate solid support, incubate with fluid sample, detect preferential antigens, compare to control, evaluate for autoimmune diseases
08/31/2010US7785804 Mammalian CX3C chemokine antibodies
08/31/2010US7785622 comprises fentanyl as active ingredient, pressure-sensitive adhesive base, and tackifier resin; pressure-sensitive adhesive base comprising polyisobutylene and styrene/isoprene/styrene block copolymer; easily produced, has long-term continuity, and is excellent in adhesion and conformability to skin
08/31/2010US7785601 administering a hematopoietic growth factor such as granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor to a mammal
08/31/2010US7785599 Albumin fusion proteins
08/31/2010US7785596 administering galectins to the brain of the vertebrates to intensify in vivo proliferation of subventricular zone astrocytes and neuron stem cells; treatment of neurodegenerative diseases, brain and nervous system disorders
08/31/2010CA2603274C Tetracyclic compounds, their preparation process and the pharmaceutical compounds containing them
08/31/2010CA2567981C Constrained himbacine analogs as thrombin receptor antagonists
08/31/2010CA2473152C Orally dispersible pharmaceutical piribedil composition
08/31/2010CA2397723C Brain, spinal and nerve injury treatment
08/31/2010CA2389545C Chemokine receptor binding heterocyclic compounds
08/31/2010CA2374226C Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
08/31/2010CA2364493C Nitrate esters and their use for neurological conditions
08/31/2010CA2262010C Hsv strain lacking functional icp27 and icp34.5 genes
08/31/2010CA2227235C Novel galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives
08/26/2010WO2010096791A1 (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
08/26/2010WO2010096778A1 Methods of and compositions for reducing cell death
08/26/2010WO2010096751A1 Compositions and methods for treating a disease mediated by soluble oligomeric amyloid beta
08/26/2010WO2010096470A2 Method for inhibiting neurodegeneration
08/26/2010WO2010096389A1 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
08/26/2010WO2010096384A2 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands
08/26/2010WO2010096371A2 Heterocyclic compounds which modulate the cb2 receptor
08/26/2010WO2010096134A1 Extended length botulinum toxin formulation for human or mammalian use
08/26/2010WO2010096045A1 Novel and potent tapentadol dosage forms
08/26/2010WO2010096011A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor
08/26/2010WO2010095943A2 Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning
08/26/2010WO2010095940A2 Glutathione-based drug delivery system
08/26/2010WO2010095926A1 Use of reveratrol for preserving cognitive functioning
08/26/2010WO2010095741A1 Novel steroid derivative and process for production thereof, and pharmaceutical preparation comprising the novel steroid derivative
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
08/26/2010WO2010095304A1 Hydrogel of polysaccharide derivatives
08/26/2010WO2010095106A1 Solid forms of ( 2r) -2- { ( is ) -6, 7 -dimethoxy- 1- [2- (4-triflu0r0methyl-phenyl) -ethyl] -3, 4-dihydr0-1h -isoquinolin-2-yl} -n-methyl-2-phenyl-acetamide hydrochloride
08/26/2010WO2010094762A1 Heteroaryl substituted pyridazinone derivatives
08/26/2010WO2010094755A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010WO2010094669A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
08/26/2010WO2010094667A1 Pyrrolidine derivatives as nk3 receptor antagonists
08/26/2010WO2010094659A1 Amine or amino alcohols as glyt1 inhibitors
08/26/2010WO2010094647A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/26/2010WO2010094645A1 Substituted pyridine derivatives and their medical use
08/26/2010WO2010094644A1 Substituted pyridine derivatives and their medical use
08/26/2010WO2010094289A1 Allosteric binding compounds
08/26/2010WO2010094242A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
08/26/2010WO2010094074A1 Pharmaceutical preparation and delivery system
08/26/2010WO2010076524A3 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
08/26/2010WO2010073104A3 Improving cognitive function
08/26/2010WO2010056988A9 Methods of treating stroke using stem cell-like menstrual blood cells
08/26/2010WO2007039781A3 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors
08/26/2010US20100217727 Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications
08/26/2010US20100216976 Sodium-independent transporter carrying acidic amino acid and its gene
08/26/2010US20100216878 Amino Acid Derivatives
08/26/2010US20100216875 Methods of treating alzheimer's disease
08/26/2010US20100216871 Use of compounds having ccr antagonism
08/26/2010US20100216868 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
08/26/2010US20100216862 Pyrrole Derivatives As Therapeutic Compounds
08/26/2010US20100216861 Amino arylsulfonamide compounds and their use as 5-ht6 ligands
08/26/2010US20100216857 Method of treating motor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
08/26/2010US20100216855 Imidazaolone derivatives,preparation thereof and biological use of same
08/26/2010US20100216846 Trisubstituted 1,2,4 triazoles
08/26/2010US20100216844 Carboxamide compounds and their use as calpain inhibitors
08/26/2010US20100216842 Narcotic Emulsion Formulations for Treatment of Cancer Pain
08/26/2010US20100216841 4-Fluoro-Piperidine T-Type Calcium Channel Antagonists
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/26/2010US20100216837 Glycine transport inhibitors
08/26/2010US20100216836 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives